Moomoo AI 已提取核心訊息
Clarke Neumann, associated with Biora Therapeutics, Inc. (BIOR), was granted 230,000 shares of common stock on February 15, 2024. The transaction was classified as a grant, indicating an award or acquisition rather than a purchase, and was carried out at no cost to Neumann. Following this transaction, Neumann's direct holdings in Biora Therapeutics increased to a total of 492,193 shares. The grant is part of an ongoing transaction, with the details reported as per regulatory requirements.
Clarke Neumann, associated with Biora Therapeutics, Inc. (BIOR), was granted 230,000 shares of common stock on February 15, 2024. The transaction was classified as a grant, indicating an award or acquisition rather than a purchase, and was carried out at no cost to Neumann. Following this transaction, Neumann's direct holdings in Biora Therapeutics increased to a total of 492,193 shares. The grant is part of an ongoing transaction, with the details reported as per regulatory requirements.
與Biora Therapeutics, Inc.（BIOR）相關的克拉克·諾伊曼於2024年2月15日獲得23萬股普通股。該交易被歸類爲贈款，表示的是授予或收購，而不是收購，並且對諾伊曼來說是免費進行的。在這筆交易之後，諾伊曼在Biora Therapeutics的直接持股量增加到總共492,193股股票。該補助金是正在進行的交易的一部分，詳細信息按監管要求報告。
與Biora Therapeutics, Inc.（BIOR）相關的克拉克·諾伊曼於2024年2月15日獲得23萬股普通股。該交易被歸類爲贈款，表示的是授予或收購，而不是收購，並且對諾伊曼來說是免費進行的。在這筆交易之後，諾伊曼在Biora Therapeutics的直接持股量增加到總共492,193股股票。該補助金是正在進行的交易的一部分，詳細信息按監管要求報告。
有用
沒用